Delivery Order SPE2DB24D3013-SPE2DB25FFFNP

Award Date 10/8/24
Potential Completion Date 10/9/24
Potential Value $9.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,292.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XARELTO 20 mg tablets. The contract has an ultimate completion date of October 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide range of...
This is a $8,780.11 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XARELTO 20 MG TABLET 90S, a prescription anticoagulant medication. The contract has a period of performance through July 22, 2024 and does not utilize a set-aside. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a...
This is a $12,249.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xarelto 20 mg tablets. It is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
This is a $9,785.71 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XARELTO 20 MG TABLET 90S, a cardiovascular medication, with a performance period through September 26, 2023. This order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $3,561.15 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XARELTO 20 MG TABLET 30S, a prescription medication, and has an ultimate completion date of June 26, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply XARELTO 20 MG TABLET 1000S. The $49,584.72 firm-fixed price contract has a completion date of September 30, 2024. It appears to be part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,205.88 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,321,040 units of the prescription medication XARELTO 10 MG TABLET 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $12,613.34, is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This is a $9,905.65 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product, with a performance period ending on May 9, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This $36,851.92 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of XARELTO 20 MG TABLET 90S, a prescription pharmaceutical product. The award is not associated with a set-aside program. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999, held by Amerisourcebergen with the DLA Troop Support Medical, for providing a comprehensive range of medical commodities to...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFFNP
    Delivery Order

This is a $9,298.21 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XARELTO 20 MG TABLET 30S. The contract has an ultimate completion date of October 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 1/7/25, 11:45 AM